Keeping an Eye on Gilead Sciences, Inc (GILD) After Insider Trading Activity

Anna Perez

Gilead Sciences, Inc’s recent filing unveils that its Officer JOHANNA MERCIER acquired Company’s shares for reported $3.52 million on Nov 17 ’25. In the deal valued at $125.86 per share,28,000 shares were bought.

Then, ANDREW DICKINSON bought 2,500 shares, generating $313,075 in total proceeds.

Before that, Telman Deborah H sold 53,646 shares. Gilead Sciences, Inc shares valued at $6,590,487 were divested by the EVP, Corporate Affairs & GC at a price of $122.85 per share. As a result of the transaction, Telman Deborah H now holds 43,676 shares, worth roughly $5.42 million.

Scotiabank initiated its Gilead Sciences, Inc [GILD] rating to a Sector outperform in a research note published on November 13, 2025; the price target was $140. A number of analysts have revised their coverage, including Daiwa Securities’s analysts, who increased its forecast for the stock in mid August from “a Neutral” to “an Outperform”. Truist also remained covering GILD and has increased its forecast on August 08, 2025 with a “Buy” recommendation from previously “Hold” rating. Needham revised its rating on July 25, 2025. It rated GILD as “a Buy” which previously was an “a Hold”.

Price Performance Review of GILD

On Monday, Gilead Sciences, Inc [NASDAQ:GILD] saw its stock fall -0.74% to $124.09. Over the last five days, the stock has gained 5.03%. Gilead Sciences, Inc shares have risen nearly 33.96% since the year began. Nevertheless, the stocks have risen 34.34% over the past one year. While a 52-week high of $127.68 was reached on 11/13/25, a 52-week low of $86.08 was recorded on 01/10/25.

Levels Of Support And Resistance For GILD Stock

The 24-hour chart illustrates a support level at 123.16, which if violated will result in even more drops to 122.22. On the upside, there is a resistance level at 125.78. A further resistance level may holdings at 127.46.

How much short interest is there in Gilead Sciences, Inc?

A steep rise in short interest was recorded in Gilead Sciences, Inc stocks on 2025-10-31, dropping by 59622.0 shares to a total of 17.98 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 18.04 million shares. There was a decline of -0.33%, which implies that there is a negative sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.